Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL1045745

CCCC[N+](CCCC)(CCCC)CCCC.O=P([O-])(O)Oc1cccc2ccccc12

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
BTN3A1 O00481 2/20 0.45
HTR1B P28222 2/20 0.41
CYP2C9 P11712 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
HTR1D P28221 1/20 0.40
HTT P42858 1/20 0.40
CETP P11597 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL4749856 1.00 BTN3A1 (0.45) BTN3A1HTR1BCYP2C9CNR1CNR2
Tetrabuthylammonium SCHEMBL1047615 0.90 BTN3A1 (0.46) BTN3A1HTR1BCYP2C9CNR1CNR2
Tetrabuthylammonium SCHEMBL3392446 0.90 HTR1B (0.43) BTN3A1HTR1BCYP2C9CNR1CNR2
SCHEMBL8883201 0.82 BTN3A1 (0.52) BTN3A1HTT
SCHEMBL29370194 0.82 BTN3A1 (0.52) BTN3A1HTT
Water SCHEMBL29475620 0.80 BTN3A1 (0.51) BTN3A1HTT
Water SCHEMBL13736613 0.80 BTN3A1 (0.51) BTN3A1HTT
Tetrabuthylammonium SCHEMBL7080335 0.78 SRC (0.44) CNR1CETP
Tetrabuthylammonium SCHEMBL5702636 0.77 HTR1B (0.44) HTR1BCYP2C9CNR1CNR2HTR1D
Tetrabuthylammonium SCHEMBL4750158 0.77 PTGS2 (0.50) HTR1BCYP2C9CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212020-B1 IMPRINTED POLYMERS WITH AFFINITY FOR PHOSPHORYLATED PEPTIDES AND PROTEINS SELLERGREN BOERJE (SE) 2018-07-04 EP disclosed
US-9329186-B2 Imprinted polymers with affinity for phosphorylated peptides and proteins MIP TECHNOLOGIES AB (SE) 2016-05-03 US disclosed
US-20110015373-A1 IMPRINTED POLYMERS WITH AFFINITY FOR PHOSPHORYLATED PEPTIDES AND PROTEINS MIP TECHNOLOGIES AB (SE) 2011-01-20 US disclosed
EP-2212020-A1 IMPRINTED POLYMERS WITH AFFINITY FOR PHOSPHORYLATED PEPTIDES AND PROTEINS MIP Technologies AB (SE) 2010-08-04 EP disclosed
WO-2009064245-A1 IMPRINTED POLYMERS WITH AFFINITY FOR PHOSPHORYLATED PEPTIDES AND PROTEINS MIP TECHNOLOGIES AB (SE) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015373-A1 IMPRINTED POLYMERS WITH AFFINITY FOR PHOSPHORYLATED PEPTIDES AND PROTEINS PHAX, ACP1, CHAMP1 BTN3A1 1072/4885HTR1B 4786/4885CYP2C9 4814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.